Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Philip Carter, Costi Alifrangis, Biancastella Cereser, Pramodh Chandrasinghe, Lisa Del Bel Belluz, Thomas Herzog, Joel Levitan, Nina Moderau, Lee Schwartzberg, Neha Tabassum, Jinrui Wen, Jonathan Krell, Justin Stebbing
Published Jan 16, 2018 · Vol. 9, No. 10 · pp. 9456-9467
Abdulraheem Alshareef, Meredith S. Irwin, Nidhi Gupta, Hai-Feng Zhang, Moinul Haque, Scott D. Findlay, Bo Kyung Alex Seong, Justine Lai, Mohammed Rayis, Sadeq Al-Dandan, Raymond Lai
Published Jan 12, 2018 · Vol. 9, No. 12 · pp. 10698-10713
Maria Breun, Alexandra Schwerdtfeger, Donato Daniel Martellotta, Almuth F. Kessler, Jose M. Perez, Camelia M Monoranu, Ralf-Ingo Ernestus, Cordula Matthies, Mario Löhr, Carsten Hagemann
Published Jan 10, 2018 · Vol. 9, No. 11 · pp. 9940-9950
